The publisher's Medical Devices sector report, "Blood Glucose Meters - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Blood Glucose Meter is an electronic diabetic management device used for measuring blood glucose levels. Continuous Glucose Monitors are covered under this segment.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to -
Blood Glucose Meter is an electronic diabetic management device used for measuring blood glucose levels. Continuous Glucose Monitors are covered under this segment.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Blood Glucose Meters under development
- the report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- the report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
- the coverage of pipeline products based on various stages of development ranging from Early development to Approved / Issued stage
- the report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Blood Glucose Meters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Blood Glucose Meters - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4a Medicom GmbH
- Abbott Diabetes Care Inc
- Advanced Biosensors-Ohio LLC
- Advanced Medical Electronics Corp
- Alertgy Inc
- ALR Technologies Inc
- Arkal Medical Inc (Inactive)
- Arkray Inc
- Azurite Technologies, Inc. (Inactive)
- Bar-Ilan University
- Baylor University
- Biofi Medical Healthcare Pvt Ltd
- Biopeak Corp
- Biorasis Inc
- BioTex Inc
- Biovotion AG
- Brain Beat Ltd
- Brigham and Women's Hospital
- Brighter AB
- CALISTO MEDICAL, INC. (Inactive)
- Callitas Therapeutics Inc
- Cardiff University
- CGM3 Ltd
- Cirtec Medical LLC
- City, University of London
- Columbia University
- ConvaTec Group Plc
- Co-Optical Inc
- Cyber Medical Ltd
- DexCom Inc
- DiaMonTech GmbH
- Echo Therapeutics Inc
- Ecole Polytechnique Federale de Lausanne
- eLutions Integrated Systems, Inc.
- Emperra GmbH E-Health Technologies
- EyeSense GmbH
- Firefly Health Pty Ltd
- Flowsion A/S
- Gili Medical Ltd
- Globe Medical Tech Inc (Inactive)
- GlucoLight Corporation (Inactive)
- GlucoMe Ltd
- Glucometrix AG
- Glucosat
- GlucoSet AS
- GlucoStats System Pte Ltd.
- Glucovation Inc
- GluMetrics Inc
- Glusense Ltd
- GlySens Inc
- G-Sense Ltd.
- iGlyko, Inc. (Inactive)
- Indigo Diabetes NV
- InLight Solutions Inc.
- Innopharmax Inc
- Innovosens AB
- Insulet Corp
- Integrated Medical Sensors
- Integrity Applications Ltd
- IntelliDx Inc (Inactive)
- Invivomon Inc (Inactive)
- Invivosense ASA (Inactive)
- I-Sens Inc
- iSense Corporation (Inactive)
- KeenCAT Technologies
- Keratin Biosciences Inc
- Know Labs Inc
- KTH Royal Institute of Technology
- Lein Applied Diagnostics Limited
- LEMM Technologies, LLC
- Lifecare AS
- LifeScan Inc
- LighTouch Medical, Inc.
- Luminous Medical Inc (Inactive)
- Lyte Labs
- Massachusetts Institute of Technology
- Medical Wireless Sensing Ltd
- Medtronic Diabetes
- Medtronic Plc
- Mellitor Ltd
- Metronom Health Inc
- mobiLIFE
- Mologic Ltd
- Movano Inc
- Nagasaki University
- Nemaura Medical Inc
- Newton Photonics Inc
- NIR Diagnostics Inc. (Inactive)
- Northwestern University
- Orsus Medical Ltd
- Pelikan Technologies, Inc. (Inactive)
- Pepex Biomedical, Inc.
- PharmaTech Solutions Inc
- Pignolo SpA
- PKvitality SAS
- POPS! Diabetes Care Inc
- PositiveID Corp
- Profusa Inc
- Purdue University
- Q Step Technologies, Inc.
- Roche Diabetes Care Inc
- Senseonics Holdings Inc
- SensiVida Medical Technologies, Inc. (Inactive)
- Sensys Medical, Inc.
- Sentec Pte Ltd
- Senzime AB
- Shield Diagnostics
- Singapore Biomicro Pte Ltd
- Socrates Health Solutions, Inc.
- Solys Diagnostics Inc
- Spire Biophotonics Lifesciences
- St. Louis Medical Devices Inc (Inactive)
- Stony Brook University
- Swansea University
- TecMed Inc
- Tenax Therapeutics Inc
- Terumo Corp
- Texas A&M University
- Ultradian Diagnostics LLC
- University of Bordeaux
- University of California Berkeley
- University of California Irvine
- University of California San Diego
- University of Central Florida
- University of South Carolina
- University of South Florida
- University of Technology Sydney
- University of Texas at Arlington
- VeriTeQ Corporation
- Virginia Commonwealth University
- Vytrace, Inc.
- WaveForm Technologies Inc
- Xcellence in Bio Innovations & Technologies Pvt Ltd
- Ypsomed Holding AG
- Zansors LLC
- Zyvex Corp
